1. Value in Health Regional Issues
Cost-Utility Analysis of Erythropoietin for Anemia Treatment in Thai End-Stage Renal Disease Patients with Hemodialysis 
Tanita Thaweethamcharoen, PhD, Rungpetch Sakulbumrungsil, PhD, Cherdchai Nopmaneejumruslers, MD, Somkiat Vasuvattakul, MD 
Value in Health Regional Issues 
Volume 3, Pages (May 2014)
DOI: /j.vhri
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Schematic representation of Markov model. CV, cardiovascular; nCV, noncardiovascular; HD, hemodialysis; HDCV, hemodialysis and cardiovascular disease.
Value in Health Regional Issues 2014 3, 44-49DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Cost-effectiveness acceptability curve of the different Hb levels compared with the Hb levels <9 g/dl. Hb, hemoglobin.
Value in Health Regional Issues 2014 3, 44-49DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions